Growth Metrics

Sarepta Therapeutics (SRPT) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 66.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 66.26%
Dec 31, 2025 -56.77%
Sep 30, 2025 7.67%
Jun 30, 2025 36.57%
Mar 31, 2025 -51.21%
Dec 31, 2024 52.23%
Sep 30, 2024 38.28%
Jun 30, 2024 83.89%
Mar 31, 2024 30.64%
Dec 31, 2023 28.95%
Sep 30, 2023 46.63%
Jun 30, 2023 1.18%
Mar 31, 2023 -5.37%
Dec 31, 2022 22.58%
Sep 30, 2022 -2.05%
Jun 30, 2022 8.47%
Mar 31, 2022 -4.38%
Dec 31, 2021 8.77%
Sep 30, 2021 21.08%
Jun 30, 2021 -17.45%
Mar 31, 2021 -70.32%
Dec 31, 2020 -94.65%
Sep 30, 2020 -44.00%
Jun 30, 2020 -29.75%
Mar 31, 2020 -44.34%
Dec 31, 2019 -37.59%
Sep 30, 2019 -29.79%
Jun 30, 2019 -64.29%
Mar 31, 2019 -8.56%
Dec 31, 2018 -29.31%
Sep 30, 2018 -10.64%
Jun 30, 2018 -34.93%
Mar 31, 2018 20.79%
Dec 31, 2017 19.71%
Sep 30, 2017 -10.88%
Jun 30, 2017 -27.90%
Mar 31, 2017 -16.03%
Dec 31, 2016 -39.09%
Sep 30, 2016 -31.37%
Jun 30, 2016 -53.75%
Mar 31, 2016 -57.04%
Dec 31, 2015 -83.88%
Sep 30, 2015 -95.71%
Jun 30, 2015 -96.41%
Mar 31, 2015 -108.00%
Dec 31, 2014 -70.64%
Sep 30, 2014 -44.03%
Jun 30, 2014 -44.06%
Mar 31, 2014 -65.61%
Dec 31, 2013 -166.27%
Sep 30, 2013 -87.26%
Jun 30, 2013 -30.62%